A German court ruled that Eli Lilly & Co. cannot prevent a competitor from selling a generic form of its key Alimta cancer drug once the patent expires this December.
WSJ.com: Law, Wall Street Journal: Business: Law
Fri, 03/06/2015 - 7:26am
A German court ruled that Eli Lilly & Co. cannot prevent a competitor from selling a generic form of its key Alimta cancer drug once the patent expires this December.